DHR · Industrials

DANAHER CORP /DE/

Ranked earnings events from SEC filings, earnings calls, press releases and news. Full Picture: what to focus on this earnings window

News · 2026-08-08

Revenue Performance and MixImportance 31 · Surprise 32
Danaher reported Q2 2026 revenue of $6.26 billion, up approximately 5.5% year over year and above analyst expectations. Core revenue growth and strong Life Sciences performance supported results, while Biotechnology…

Revenue Performance and MixImportance 31 · Surprise 32
Danaher reported Q2 2026 revenue of $6.26 billion, up approximately 5.5% year over year and above analyst expectations. Core revenue growth and strong Life Sciences performance supported results, while Biotechnology…
Leadership TransitionImportance 31 · Surprise 42
Danaher appointed Julie Sawyer Montgomery as President and CEO effective October 1, 2026. Montgomery, currently an executive vice president and leader of the Diagnostics platform, will succeed Rainer Blair, who is…

Leadership TransitionImportance 31 · Surprise 42
Danaher appointed Julie Sawyer Montgomery as President and CEO effective October 1, 2026. Montgomery, currently an executive vice president and leader of the Diagnostics platform, will succeed Rainer Blair, who is…

Revenue Performance and MixImportance 31 · Surprise 32
Danaher reported Q2 2026 revenue of $6.26 billion, up approximately 5.5% year over year and above analyst expectations. Core revenue growth and strong Life Sciences performance supported results, while Biotechnology…
Leadership TransitionImportance 31 · Surprise 42
Danaher appointed Julie Sawyer Montgomery as President and CEO effective October 1, 2026. Montgomery, currently an executive vice president and leader of the Diagnostics platform, will succeed Rainer Blair, who is…

Revenue Performance and MixImportance 31 · Surprise 32
Danaher reported Q2 2026 revenue of $6.26 billion, up approximately 5.5% year over year and above analyst expectations. Core revenue growth and strong Life Sciences performance supported results, while Biotechnology…
Leadership TransitionImportance 31 · Surprise 42
Danaher appointed Julie Sawyer Montgomery as President and CEO effective October 1, 2026. Montgomery, currently an executive vice president and leader of the Diagnostics platform, will succeed Rainer Blair, who is…